(Q43417806)

23 November 2017

1 reference

title

Systemic amyloidosis and the gastrointestinal tract (English)

1 reference

23 November 2017

1 reference

Friedman S

1

1 reference

23 November 2017

Janowitz HD

series ordinal

2

1 reference

23 November 2017

publication date

1 September 1998

1 reference

Gastroenterology Clinics of North America

23 November 2017

published in

1 reference

23 November 2017

volume

27

1 reference

23 November 2017

issue

3

1 reference

23 November 2017

page(s)

595-614, vi

1 reference

Oral amyloidosis: two unusual case presentations.

23 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970022-4

7 January 2021

Primary salivary gland amyloidosis causing sicca syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970022-4

7 January 2021

Liver transplantation in Japanese patients with familial amyloidotic polyneuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970022-4

7 January 2021

Cardiac and pleuropulmonary AL amyloid imaging with technetium-99m labelled aprotinin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970022-4

7 January 2021

The familial Mediterranean fever gene--cloned at last

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970022-4

7 January 2021

Crohn's ileitis complicated by amyloidosis: observations and therapeutic considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970022-4

7 January 2021

Amyloid and amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970022-4

7 January 2021

Amyloidosis and plasma cell dyscrasias: gastrointestinal involvement

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970022-4

7 January 2021

Clinical aspects of amyloidosis, including related proteins and central nervous system amyloid.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970022-4

7 January 2021

History of amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970022-4

7 January 2021

Primary (AL) amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970022-4

7 January 2021

Proteins of the systemic amyloidoses.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970022-4

7 January 2021

The pathogenesis and biochemistry of amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970022-4

7 January 2021

Advances in amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970022-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970022-4

1 reference

7 January 2021

Serum amyloid-A protein concentration in inflammatory diseases and its relationship to the incidence of reactive systemic amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970022-4

7 January 2021

Correlation of persistently high serum amyloid A protein and C-reactive protein concentrations with rapid progression of secondary amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970022-4

7 January 2021

The systemic amyloidoses

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970022-4

7 January 2021

Pathophysiology of diarrhea in patients with familial amyloid neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970022-4

7 January 2021

Amyloidosis and granulomatous ileocolitis. Regression after surgical removal of the involved bowel

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970022-4

7 January 2021

Beta-2-microglobulin-associated amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970022-4

7 January 2021

PERIPHERAL AND AUTONOMIC NERVE INVOLVEMENT IN PRIMARY AMYLOIDOSIS ASSOCIATED WITH UNCONTROLLABLE DIARRHOEA AND STEATORRHOEA

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970022-4

7 January 2021

Amyloidosis: prognosis and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970022-4

7 January 2021

Hepatic amyloidosis (primary [AL], immunoglobulin light chain): the natural history in 80 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970022-4

7 January 2021

Amyloidosis and the gut

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970022-4

7 January 2021

Amyloidosis complicating inflammatory bowel disease. A case report and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970022-4

7 January 2021

Amyloid proteins and amyloidoses: complexity updated

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970022-4

7 January 2021

Colonic perforation by amyloidosis. Report of a case

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970022-4

7 January 2021

Primary amyloidosis causing macroglossia and respiratory symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970022-4

7 January 2021

Imaging amyloidosis with radiolabelled SAP

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970022-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970022-4

1 reference

7 January 2021

HEPATIC AMYLOIDOSIS WITH PORTAL HYPERTENSION

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970022-4

7 January 2021

Amyloidosis of the colon. Report of a case and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970022-4

7 January 2021

A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970022-4

7 January 2021

Gastrointestinal manifestations of amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970022-4

7 January 2021

Use of abdominal fat tissue aspirate in the diagnosis of systemic amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970022-4

7 January 2021

Therapy of amyloid diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970022-4

7 January 2021

Long-term survival in systemic amyloid A amyloidosis complicating Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970022-4

7 January 2021

The incidence of amyloidosis complicating inflammatory bowel disease. A prospective survey of 177 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970022-4

7 January 2021

Regression of amyloid in Crohn's disease after bowel resection. A 19-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970022-4

7 January 2021

Symptomatic gastric amyloidosis in patients with primary systemic amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970022-4

7 January 2021

Familial Mediterranean fever-associated amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970022-4

7 January 2021

Colchicine therapy of the renal amyloidosis of ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970022-4

7 January 2021

Esophageal manometry in systemic amyloidosis. A study of 30 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970022-4

7 January 2021

The Spectrum of Roentgen Appearance in Amyloidosis of the Small and Large Bowel: Radiologic-Pathologic Correlation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970022-4

7 January 2021

Treatment of 100 patients with primary amyloidosis: a randomized trial of melphalan, prednisone, and colchicine versus colchicine only.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970022-4

7 January 2021

Endoscopic and biopsy findings of the upper digestive tract in patients with amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970022-4

7 January 2021

Endoscopic features in amyloidosis of the small intestine: clinical and morphologic differences between chemical types of amyloid protein

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970022-4

7 January 2021

Intestinal pseudo-obstruction in patients with amyloidosis: clinicopathologic differences between chemical types of amyloid protein

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970022-4

7 January 2021

The clinical and biochemical spectrum of hereditary amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970022-4

7 January 2021

Amyloidosis in regional enteritis. A report of five cases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970022-4

7 January 2021

Octreotide for diarrhea in amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970022-4

7 January 2021

Gastrointestinal amyloid deposition in AL (primary or myeloma-associated) and AA (secondary) amyloidosis: diagnostic value of gastric biopsy.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970022-4

7 January 2021

Bleeding manifestations in 100 patients with amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970022-4

7 January 2021

10.1016/S0889-8553(05)70022-4

Identifiers

DOI

1 reference

23 November 2017

1 reference